1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Algernon Pharmaceuticals Acquires NIC

M&A Deal Summary

Algernon Pharmaceuticals Acquires NIC

On May 13, 2025, Algernon Pharmaceuticals acquired life science company NIC

Acquisition Highlights
  • This is Algernon Pharmaceuticals’ 1st transaction in the Life Science sector.
  • This is Algernon Pharmaceuticals’ 1st transaction in the United States.

M&A Deal Summary
Date 2025-05-13
Target NIC
Sector Life Science
Buyer(s) Algernon Pharmaceuticals
Deal Type Add-on Acquisition

Target

NIC

United States
NIC is a clinical stage drug development company.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Algernon Pharmaceuticals

Vancouver, British Columbia, Canada
Category Company
Sector Life Science
DESCRIPTION

Algernon Pharmaceuticals is a healthcare and clinical stage pharmaceutical development company investigating multiple drugs for unmet global medical needs. Algernon Pharmaceuticals is headquartered in Vancouver, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal